FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1255587009: Regression of neoplasm (qualifier value)

Status: current, Primitive. Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5147713013 Regression of neoplasm (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core
5147714019 Regression of neoplasm en Synonym Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Regression of neoplasm Is a Pathological process true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Presence of regression of primary malignant neoplasm of oesophagus after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of anus after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of pancreas after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of metastatic neoplasm of breast in lymph node after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 5
Presence of regression of primary malignant neoplasm of liver after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of prostate after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of stomach after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of fallopian tube after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of ovary after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of lung after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of breast after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of thymus after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of soft tissue after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant neoplasm of bone after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant melanoma of skin Characterizes True Regression of neoplasm Inferred relationship Some 5
Presence of regression of primary malignant neoplasm of peritoneum after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant mesothelioma after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 5
Presence of regression of primary malignant neoplasm of colon after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 5
Presence of regression of primary malignant neoplasm of central nervous system after neoadjuvant antineoplastic therapy Characterizes True Regression of neoplasm Inferred relationship Some 6

Reference Sets

Qualifier value foundation reference set

Back to Start